{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=everolimus-eluting+stent", "query": { "intervention": "everolimus-eluting stent" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 45, "total_pages": 5, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=everolimus-eluting+stent&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-23T12:02:34.620Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04282148", "title": "Abbott Next Generation Drug Eluting Stent 48mm Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Coronary Artery Disease" ], "interventions": [ { "name": "ABT NG DES 48 EECSS", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Abbott Medical Devices", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 107, "start_date": "2020-06-17", "completion_date": "2023-09-17", "has_results": true, "last_update_posted_date": "2025-01-08", "last_synced_at": "2026-09-23T12:02:34.620Z", "location_count": 18, "location_summary": "Scottsdale, Arizona • La Jolla, California • Santa Monica, California + 13 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "La Jolla", "state": "California" }, { "city": "Santa Monica", "state": "California" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04282148" }, { "nct_id": "NCT04562532", "title": "Firehawk Rapamycin Target Eluting Coronary Stent North American Trial", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Coronary Artery Disease" ], "interventions": [ { "name": "Microport Firehawk stent", "type": "DEVICE" }, { "name": "2nd generation DES (XIENCE family, Promus family, Resolute/Onyx family/Endeavor, and Orsiro stent)", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Shanghai MicroPort Medical (Group) Co., Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1720, "start_date": "2021-02-17", "completion_date": "2027-06-30", "has_results": false, "last_update_posted_date": "2024-07-24", "last_synced_at": "2026-09-23T12:02:34.620Z", "location_count": 44, "location_summary": "Birmingham, Alabama • Gilbert, Arizona • La Jolla, California + 38 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "La Jolla", "state": "California" }, { "city": "Riverside", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04562532" }, { "nct_id": "NCT03048825", "title": "Colchicine and Spironolactone in Patients with MI / SYNERGY Stent Registry", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "ST Elevation Myocardial Infarction", "Non ST Elevation Myocardial Infarction" ], "interventions": [ { "name": "Colchicine", "type": "DRUG" }, { "name": "Spironolactone", "type": "DRUG" }, { "name": "SYNERGY Bioabsorbable Polymer Drug-Eluting Stent", "type": "DEVICE" }, { "name": "Colchicine-Placebo", "type": "DRUG" }, { "name": "Spironolactone-Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Population Health Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 7264, "start_date": "2018-02-01", "completion_date": "2024-08-09", "has_results": false, "last_update_posted_date": "2024-10-15", "last_synced_at": "2026-09-23T12:02:34.620Z", "location_count": 11, "location_summary": "Bakersfield, California • Washington D.C., District of Columbia • Chicago, Illinois + 8 more", "locations": [ { "city": "Bakersfield", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Springfield", "state": "Illinois" }, { "city": "Munster", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT03048825" }, { "nct_id": "NCT01435031", "title": "EXPERT CTO: Evaluation of the XIENCE PRIME™ LL and XIENCE Nano™ Everolimus Eluting Coronary Stent Coronary Stents, Performance, and Technique in Chronic Total Occlusions", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Coronary Artery Disease (CAD)", "Chronic Total Occlusion (CTO)" ], "interventions": [ { "name": "CTO Treatment Device", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Abbott Medical Devices", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 250, "start_date": "2011-09", "completion_date": "2017-12", "has_results": true, "last_update_posted_date": "2018-05-09", "last_synced_at": "2026-09-23T12:02:34.620Z", "location_count": 1, "location_summary": "Santa Clara, California", "locations": [ { "city": "Santa Clara", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01435031" }, { "nct_id": "NCT06271590", "title": "MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Coronary Artery Disease", "Native Coronary Artery Stenosis", "Cardiovascular Diseases" ], "interventions": [ { "name": "Sirolimus Drug Coated Balloon", "type": "DEVICE" }, { "name": "Drug eluting stents (DES)", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Concept Medical Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 1605, "start_date": "2025-05-20", "completion_date": "2031-11", "has_results": false, "last_update_posted_date": "2025-09-11", "last_synced_at": "2026-09-23T12:02:34.620Z", "location_count": 24, "location_summary": "Gilbert, Arizona • Los Angeles, California • Clearwater, Florida + 19 more", "locations": [ { "city": "Gilbert", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Clearwater", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Tallahassee", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06271590" }, { "nct_id": "NCT00638794", "title": "Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Coronary Artery Disease" ], "interventions": [ { "name": "Drug -Eluting Stent (Taxus™, Cypher®, Endeavor™, Xience V™)", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Cardiovascular Research Foundation, New York", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 8575, "start_date": "2008-01", "completion_date": "2013-01", "has_results": false, "last_update_posted_date": "2013-01-23", "last_synced_at": "2026-09-23T12:02:34.620Z", "location_count": 8, "location_summary": "Minneapolis, Minnesota • New York, New York • Charlotte, North Carolina + 5 more", "locations": [ { "city": "Minneapolis", "state": "Minnesota" }, { "city": "New York", "state": "New York" }, { "city": "Charlotte", "state": "North Carolina" }, { "city": "Greensboro", "state": "North Carolina" }, { "city": "Pinehurst", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00638794" }, { "nct_id": "NCT00180479", "title": "SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Stents", "Coronary Artery Disease", "Total Coronary Occlusion", "Coronary Artery Restenosis", "Stent Thrombosis", "Vascular Disease", "Myocardial Ischemia", "Coronary Artery Stenosis" ], "interventions": [ { "name": "XIENCE V® Everolimus Eluting Coronary Stent", "type": "DEVICE" }, { "name": "TAXUS® EXPRESS2™ Paclitaxel Eluting Coronary Stent", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Abbott Medical Devices", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1002, "start_date": "2005-06", "completion_date": "2011-11", "has_results": true, "last_update_posted_date": "2011-11-23", "last_synced_at": "2026-09-23T12:02:34.620Z", "location_count": 65, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • La Jolla, California + 56 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00180479" }, { "nct_id": "NCT02316886", "title": "Preventive PCI or Medical Therapy Alone for Vulnerable Atherosclerotic Coronary Plaque", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Coronary Artery Disease", "Plaque, Atherosclerotic" ], "interventions": [ { "name": "Coronary intervention", "type": "DEVICE" }, { "name": "Optimal Medical treatment", "type": "DRUG" } ], "intervention_types": [ "DEVICE", "DRUG" ], "sponsor": "Seung-Jung Park", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1608, "start_date": "2015-10-05", "completion_date": "2023-10-19", "has_results": false, "last_update_posted_date": "2023-11-18", "last_synced_at": "2026-09-23T12:02:34.620Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02316886" }, { "nct_id": "NCT03350542", "title": "A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Coronary Artery Disease" ], "interventions": [ { "name": "SYNERGY 48 mm", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Boston Scientific Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2018-04-12", "completion_date": "2021-01-08", "has_results": true, "last_update_posted_date": "2021-05-14", "last_synced_at": "2026-09-23T12:02:34.620Z", "location_count": 8, "location_summary": "Birmingham, Alabama • Saint Paul, Minnesota • New York, New York + 5 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Saint Paul", "state": "Minnesota" }, { "city": "New York", "state": "New York" }, { "city": "Raleigh", "state": "North Carolina" }, { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT03350542" }, { "nct_id": "NCT01249027", "title": "XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval, Single-Arm Study", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Angioplasty", "Chronic Coronary Occlusion", "Stent Thrombosis", "Vascular Disease", "Myocardial Ischemia", "Coronary Artery Stenosis", "Coronary Disease", "Coronary Artery Disease", "Coronary Restenosis" ], "interventions": [ { "name": "XIENCE V® Everolimus Eluting Coronary Stent System (EECSS)", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Abbott Medical Devices", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 2605, "start_date": "2010-11", "completion_date": "2017-01", "has_results": true, "last_update_posted_date": "2019-03-01", "last_synced_at": "2026-09-23T12:02:34.620Z", "location_count": 1, "location_summary": "Santa Clara, California", "locations": [ { "city": "Santa Clara", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01249027" } ] }